1 |
Canonical pathway |
Requires two signals: priming (via NF-κB) and activation (via danger signals) |
PAMPs (LPS, bacterial toxins), DAMPs |
28
|
2 |
Non-canonical pathway |
Involves caspase-11 (mouse) or caspase-4/5 (human) activation by intracellular LPS |
Intracellular Gram-negative bacteria |
29
|
3 |
Efflux of potassium ions (K+) |
Decrease in intracellular efflux of potassium ions triggers NLRP3 oligomerization |
ATP-P2X7 receptor activation |
30
|
4 |
Calcium (Ca2+) signaling |
Increased cytosolic calcium (Ca2+) signaling enhances inflammasome activation |
Endoplasmic reticulum stress, ionophores |
31
|
5 |
Lysosomal rupture |
Release of cathepsins and DAMPs from damaged lysosomes |
Silica, cholesterol crystals, amyloid-β |
32
|
6 |
Mitochondrial dysfunction |
ROS production and mitochondrial damage promote NLRP3 activation |
Oxidative stress, viral infections |
33
|
7 |
ATP release and P2X7 activation |
Extracellular ATP binds to the P2X7 receptor, triggering efflux of potassium ions |
Cellular damage, inflammation |
34
|
8 |
NEK7 interaction |
NEK7 binds NLRP3 to promote its oligomerization |
ROS, ion flux |
5
|